KraneShares Trust KraneShares C (KWEB)

Executive Summary

KWEB declined 2.87% to $28.41 since the April 22 report, breaching the $29 support level and extending YTD losses to -16.58% amid a challenging 6-month period that has seen the ETF decline 29.46%. Despite this technical deterioration, emerging bullish catalysts include multiple institutional forecasts for 10% upside by year-end, strengthening safe-haven demand for Chinese assets amid geopolitical tensions, and growing international adoption of Chinese AI services at one-third the cost of Western alternatives, creating a divergence between near-term price weakness and improving fundamental outlook.

Key Updates

KWEB has declined 2.87% to $28.41 since the April 22 report, breaking below the $29 support level that had been tested in previous sessions. The ETF now trades significantly below the psychological $30 threshold, with the current price representing a 16.58% YTD decline and a severe 29.46% six-month drawdown. The 5-day decline of 5.63% indicates accelerating downward momentum, though the 1-month performance of +0.44% suggests some stabilization attempts at these depressed levels. This price action occurs against a backdrop of increasingly positive institutional sentiment, with Eurizon SLJ Capital projecting 10% gains by year-end and the CSI 300 benchmark potentially reaching above 5,100 from 4,646.16.

Current Trend

KWEB remains in a confirmed downtrend with YTD losses of 16.58% and consecutive breaches of key support levels at $30 and $29. The 6-month decline of 29.46% represents a substantial drawdown from previous levels, placing the ETF at critical technical junctures. However, market structure is showing signs of potential inflection, with Chinese onshore shares gaining 4.4% through mid-April and the CSI 300 posting approximately 25% gains over the twelve-month period despite YTD weakness. The ETF's current price of $28.41 represents extreme undervaluation relative to institutional price targets, with Eurizon forecasting the CSI 300 rising to above 5,000, implying significant upside potential. The 1-month marginal gain of 0.44% suggests accumulation at these levels, though broader momentum remains negative.

Investment Thesis

The investment thesis for KWEB centers on Chinese internet and technology companies trading at historically discounted valuations with multiple structural catalysts emerging. The CSI 300's current price-to-earnings ratio of 18 remains discounted relative to global peers, while household savings currently yield only 1.8% in bonds, creating conditions for capital rotation into equities. Chinese AI companies are establishing competitive advantages through substantially lower development costs—approximately one-third of Western alternatives—with major players including Tencent, Alibaba, Baidu, and ByteDance competing for international market share. The property market stabilization, dovish regulatory environment, and expected 5-10% earnings growth provide fundamental support, while global funds remain underweighted and have only recently reached benchmark-neutral levels for the first time since 2022. Additional catalysts include China's energy independence positioning the country as a safe-haven amid geopolitical tensions and potential Middle East conflict resolution.

Thesis Status

The investment thesis is strengthening despite deteriorating price action, creating a classic divergence between technical and fundamental indicators. Multiple institutional forecasts now support the bull case, with Eurizon SLJ Capital projecting 10% gains by year-end and ChinaAMC's China Opportunities Fund delivering 15% YTD returns while outperforming 98% of peers. The thesis that Chinese tech companies would benefit from AI adoption is materializing, with international users adopting Chinese AI services through platforms like OpenClaw due to significant cost advantages. However, the thesis faces near-term headwinds from continued global fund underweighting and technical breakdown below key support levels. The stabilization of property markets and improving supply-demand dynamics validate earlier thesis components, while the positive correlation between stocks and bonds since March 18 confirms safe-haven demand. The timing of thesis validation remains uncertain, with current price action suggesting the market has not yet priced in the improving fundamental outlook.

Key Drivers

Institutional capital allocation is emerging as a primary driver, with JPMorgan pursuing regulatory approval for active ETFs in mainland China as part of a broader Asia-Pacific expansion strategy targeting $600 billion in regional AUM. The AI sector is demonstrating competitive positioning, with portfolio managers maintaining bullish stances on Chinese AI stocks, arguing they are not in bubble territory and benefit from lower development costs, with major companies like Tencent and Alibaba only recently accelerating investments. Geopolitical dynamics are shifting in China's favor, with Chinese assets demonstrating resilience due to energy independence and limited Middle East exposure, driving the first positive stock-bond correlation in two years. Healthcare sector opportunities are expanding, with China's cost advantages in drug development and rising outbound licensing deals attracting 24% allocations from top-performing funds. Export competitiveness is strengthening corporate profitability, while government support programs like Shenzhen's $1 million developer incentives are positioning Chinese AI services for international adoption.

Technical Analysis

KWEB has broken critical support at $29.00, now trading at $28.41 with accelerating downward momentum evidenced by the 5-day decline of 5.63%. The ETF has established a pattern of lower lows, with the current price representing a 29.46% decline from 6-month highs and a 16.58% YTD loss. Key resistance levels now exist at $29.00 (former support), $30.00 (psychological barrier), and $30.55 (April 17 level). The nearest support appears at $28.00, with further downside risk to the $27.00 level if current selling pressure continues. However, the 1-month performance of +0.44% suggests potential base-building at these levels, indicating some accumulation despite broader weakness. Volume patterns and momentum indicators point to oversold conditions, though no definitive reversal signals have emerged. The technical deterioration contrasts sharply with improving fundamental catalysts, suggesting the ETF may be approaching an inflection point where value buyers could emerge, particularly given institutional price targets implying 10-15% upside from current levels.

Bull Case

• Multiple institutional forecasts project 10% upside by year-end: Eurizon SLJ Capital expects the CSI 300 to reach above 5,100 from 4,646.16, supported by dovish regulatory policies, 5-10% earnings growth, and stabilizing property markets, while household savings yielding only 1.8% in bonds create conditions for equity rotation.
• Chinese AI services gaining international adoption at one-third Western costs: Chinese AI providers including Zhipu, Minimax, Moonshot, Tencent, Alibaba, Baidu, and ByteDance are competing for OpenClaw deployments with pricing approximately one-third of Anthropic's Claude, supported by government incentives such as Shenzhen's $1 million support program.
• Top-performing funds demonstrating exceptional returns through Chinese exposure: ChinaAMC's China Opportunities Fund delivered 15% YTD returns, outperforming 98% of peers, with portfolio manager Leo Fan maintaining bullish stance on AI stocks and 24% healthcare allocation capitalizing on cost advantages in drug development.
• Safe-haven demand driving unprecedented stock-bond correlation: Chinese assets entered first positive correlation in two years from March 18, with onshore shares gaining 4.4% while 10-year bond yields rose only 3 basis points, significantly outperforming French, US, and German counterparts which rose at least 40 basis points each.
• Major institutional expansion signals long-term confidence: JPMorgan pursuing regulatory approval for active ETFs in mainland China as part of Asia-Pacific strategy to double regional AUM to $600 billion within five years, while currently serving over 69 million retail and institutional clients.

Bear Case

• Severe technical breakdown with 29.46% six-month decline: KWEB has breached critical support levels at $30 and $29, now trading at $28.41 with accelerating 5-day losses of 5.63% and YTD decline of 16.58%, indicating sustained selling pressure and lack of buyer conviction at current levels.
• Ex-China funds attracting capital despite performance disadvantage: iShares MSCI Emerging Markets ex China ETF dominates with approximately $17 billion in assets, while investors continue holding ex-China funds for personal values, legal restrictions in certain U.S. states, and institutional preferences for independent China allocation decisions.
• Security concerns limiting Chinese AI adoption: Chinese authorities have banned OpenClaw applications from government and banking networks, while technical complexity requiring Terminal interface familiarity creates significant barriers to mainstream global adoption.
• Chinese stocks gained only 1.5% YTD despite institutional optimism: Chinese stocks remain underweighted by global funds and posted minimal gains in 2026, suggesting institutional forecasts may not materialize in the near term despite twelve-month returns of 25%.
• Positive correlation may not persist beyond geopolitical tensions: Analysts caution the rare stock-bond correlation may not persist once Middle East tensions ease, potentially removing a key support factor for Chinese equity performance and safe-haven demand.